Sponsor or institution

Clinical trials and research at AIDS Malignancy Consortium

• 7Clinical trials
• 6Countries

Newest trials

All recruiting trials (7)

• Nirogacestat in skin Kaposi sarcoma

  This phase 2 trial tests whether nirogacestat can shrink or control skin Kaposi sarcoma in people with AIDS-related KS.

  Recruiting Phase 2 AIDS Malignancy Consortium · St Louis, Missouri · NCT07539454

• Propranolol for Kaposi Sarcoma

  This study tests whether propranolol can help treat Kaposi sarcoma in children and adults.

  Recruiting Phase 2 AIDS Malignancy Consortium · Buenos Aires and 5 other locations · NCT05797662

• Collecting blood and tissue samples for HIV/AIDS-related cancer research

  This study is collecting blood and tissue samples from people living with HIV and related cancers to help researchers learn more about how HIV affects cancer development.

  Recruiting at 8 sites AIDS Malignancy Consortium · La Jolla, California and 7 other locations · NCT05663502

• CAR-T therapy for HIV-related aggressive B-cell lymphoma

  This study is testing a new CAR-T therapy to see if it can safely help people with HIV-related aggressive B-cell lymphoma that hasn't responded to other treatments.

  Recruiting at 7 sites Phase 1 AIDS Malignancy Consortium · Duarte, California and 6 other locations · NCT05077527

• Using smartphone support to help people with HIV quit smoking during lung cancer screening

  This study is testing whether a smartphone program can help people with HIV quit smoking while they are getting screened for lung cancer.

  Recruiting at 11 sites AIDS Malignancy Consortium · La Jolla, California and 10 other locations · NCT04949464

• Surgical removal of eye-surface squamous tumors in people living with HIV in Sub-Saharan Africa

  We will try surgical removal of suspected eye-surface squamous tumors in people living with HIV in sub‑Saharan Africa and follow them for 12 months to see how surgery, tissue testing, and follow-up care work.

  Recruiting AIDS Malignancy Consortium · Kampala · NCT04704648

• Daratumumab plus dose-adjusted EPOCH for plasmablastic lymphoma

  This treatment tries adding the antibody daratumumab to DA-EPOCH chemotherapy to see if it helps people with newly diagnosed stage I–IV plasmablastic lymphoma.

  Recruiting at 9 sites Early Phase 1 AIDS Malignancy Consortium · Miami, Florida and 8 other locations · NCT04139304

Quick answers

How many clinical trials run by AIDS Malignancy Consortium are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in United States (5 trials), Uganda (2 trials), Argentina (1 trial), Brazil (1 trial), Mexico (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Early Phase 1: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →